Literature DB >> 20376644

Exercise capacity is the most powerful predictor of 2-year mortality in patients with left ventricular systolic dysfunction.

Rona K Reibis1, Andras Treszl, Karl Wegscheider, Bettina Ehrlich, Rüdiger Dissmann, Heinz Völler.   

Abstract

BACKGROUND: There are few data about predictors of cardiovascular mortality and rehospitalization rate in patients with left ventricular systolic dysfunction (LVSD) after myocardial revascularization and optimization of pharmacological treatment. PATIENTS AND METHODS: 1,346 consecutive patients with left ventricular ejection fraction (LVEF) < 45% (64 + or - 10 years, 73% male, LVEF 36.3% + or - 8%), who were referred for inpatient cardiac rehabilitation, were followed prospectively for 731 + or - 215 days in a unicentric prospective longitudinal registry. Multivariate logistic regression Cox models were used to analyze demographic, echocardiographic and exercise variables in order to determine independent predictors of cardiovascular mortality and rehospitalization.
RESULTS: LVEF failed to show prognostic power (hazard ratio [HR] 0.99 [95% confidence interval, CI, 0.94-1.03]; p = not significant), whereas moderate to severe mitral regurgitation (HR, 5.71 [95% CI 1.75-18.6]; p = 0.004) and atrial fibrillation (HR 1.67 [95% CI 1.15-2.44]; p = 0.008) were associated with a poorer prognosis. In an optimized multivariate model, 6-min walk test (HR 0.93 [95% CI 0.86-1.00] per 50 m; p = 0.049) and symptom-limited maximum exercise capacity test (HR 0.83 [95% CI 0.76-0.91] per 10 W; p < 0.001) as well as female gender (HR 0.58 [95% CI 0.39-0.84]; p = 0.005) were strong predictors for reduced overall mortality.
CONCLUSION: In patients with LVSD, independently of LVEF, traditional prognostic factors including atrial fibrillation or mitral regurgitation predict poorer survival, whereas symptom-limited exercise capacity and walking distance performed in 6-min walk test were highly predictive for a good prognosis.

Entities:  

Mesh:

Year:  2010        PMID: 20376644     DOI: 10.1007/s00059-010-3226-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  41 in total

1.  Determining prognosis in congestive heart failure: role of the 6-minute walk test.

Authors:  V Bittner
Journal:  Am Heart J       Date:  1999-10       Impact factor: 4.749

2.  The 6-minute walk test and prognosis in chronic heart failure--the available evidence.

Authors:  R Sharma; S D Anker
Journal:  Eur Heart J       Date:  2001-03       Impact factor: 29.983

3.  Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison.

Authors:  Ross Arena; Jonathan Myers; Syed Salman Aslam; Elsa B Varughese; Mary Ann Peberdy
Journal:  Am Heart J       Date:  2004-02       Impact factor: 4.749

Review 4.  The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature.

Authors:  Pompilio Faggiano; Antonio D'Aloia; Anna Gualeni; Loretta Brentana; Livio Dei Cas
Journal:  Eur J Heart Fail       Date:  2004-10       Impact factor: 15.534

5.  The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  1997-05       Impact factor: 29.983

6.  More 'malignant' than cancer? Five-year survival following a first admission for heart failure.

Authors:  S Stewart; K MacIntyre; D J Hole; S Capewell; J J McMurray
Journal:  Eur J Heart Fail       Date:  2001-06       Impact factor: 15.534

7.  Prognostic significance of echocardiographically defined mitral regurgitation early after acute myocardial infarction.

Authors:  Graham S Hillis; Jacob E Møller; Patricia A Pellikka; Malcolm R Bell; Grace C Casaclang-Verzosa; Jae K Oh
Journal:  Am Heart J       Date:  2005-12       Impact factor: 4.749

8.  Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.

Authors:  James B Young; Mark E Dunlap; Marc A Pfeffer; Jeffrey L Probstfield; Alain Cohen-Solal; Rainer Dietz; Christopher B Granger; Jaromir Hradec; Jerzy Kuch; Robert S McKelvie; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Peter Held; Scott D Solomon; Salim Yusuf; Karl Swedberg
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

9.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

Authors:  G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

10.  Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: a meta-analysis.

Authors:  Marcos R de Sousa; Carlos A Morillo; Fábio T Rabelo; Antônio M Nogueira Filho; Antonio L P Ribeiro
Journal:  Eur J Heart Fail       Date:  2008-08-09       Impact factor: 15.534

View more
  2 in total

1.  Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis.

Authors:  Iván José Fuentes-Abolafio; Brendon Stubbs; Luis Miguel Pérez-Belmonte; María Rosa Bernal-López; Ricardo Gómez-Huelgas; Antonio Ignacio Cuesta-Vargas
Journal:  BMC Cardiovasc Disord       Date:  2020-12-09       Impact factor: 2.298

2.  Exercise training in the treatment of paroxysmal atrial fibrillation: study protocol of the Cologne ExAfib Trial.

Authors:  Jonas Zacher; Katrin Dillschnitter; Hans-Georg Predel; Moritz Schumann; Nils Freitag; Thorsten Kreutz; Birna Bjarnason-Wehrens; Wilhelm Bloch
Journal:  BMJ Open       Date:  2020-10-31       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.